No evidence in favor of a more deleterious impact of a major depressive episode on verbal memory in older patients with antidepressant response

被引:0
|
作者
Blandin, Elise [1 ,2 ]
Carle, Guilhem [3 ]
Theuil, Benoit [4 ]
Katz, Julien [5 ]
Gorwood, Philip [1 ,2 ]
机构
[1] Univ Paris 05, CMME Grp Hosp St Anne, Paris, France
[2] INSERM, Ctr Psychiat & Neurosci, U894, F-75014 Paris, France
[3] Sect 17 Ctr Hosp St Anne, F-75014 Paris, France
[4] SHU Grp Hosp St Anne, F-75014 Paris, France
[5] Hop H Mondor A Chenevier, AP HP, Pole Psychiat, F-94000 Paris, France
关键词
depressive episodes; memory impairment; elderly patients; neurotoxicity; age; lifetime; HIPPOCAMPAL VOLUME; DISORDER; LIFE; DYSFUNCTION; IMPAIRMENT; SYMPTOMS; DEMENTIA; THERAPY; RISK;
D O I
10.1017/S1041610215000228
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Background: Older patients may be more vulnerable to the deleterious effect of depressive episodes on delayed narrative memory, a cognitive task which reflects hippocampal activity. We aimed to disentangle which factors could explain such increased vulnerability in the elderly, including the poorer response to treatment, a longer lifetime exposure to past depressive episodes, and lower baseline memory skills. Methods: From an initial sample of 8,229 depressed outpatients, we focused on the 2,424 treatment responders, and compared older (65 years old and over, N = 233) to younger (N= 2,191) ones. These patients were included through general practitioners' assessment and tested for the Wechsler delayed paragraph recall index, a valid and sensitive test assessing verbal declarative memory (and a marker of the hippocampal function), at baseline and after six weeks of treatment. Results: As expected, older patients after response to antidepressants showed decreased narrative memory abilities compared to younger ones. As baseline memory performance and residual depressive symptoms were also found in excess in this sample, they could act as confounders. Indeed, after controlling for these two factors, the role of age in memory performance after treatment response was ruled out. Conclusions: The potential "toxicity" of a depressive episode to cognitive functions related to the hippocampus may not be more critical in older patients compared to younger ones. Limiting remaining depressive symptoms in older depressed patients might be a way to counteract the observed worsening of memory functions in depressed patients.
引用
收藏
页码:1477 / 1484
页数:8
相关论文
共 50 条
  • [41] Changes in hippocampal volume, 5-HT4 receptor binding, and verbal memory over the course of antidepressant treatment in major depressive disorder
    Jensen, Kristian. H. Reveles
    Dam, Vibeke H.
    Kohler-Forsberg, Kristin
    Ozenne, Brice
    Stenbaek, Dea S.
    Ganz, Melanie
    Fisher, Patrick MacDonald
    Frokjaer, Vibe Gedsoe
    Knudsen, Gitte M.
    Jorgensen, Martin Balslev
    JOURNAL OF PSYCHIATRIC RESEARCH, 2025, 181 : 197 - 205
  • [42] Response to 4-month treatment with reboxetine in Parkinson's disease patients with a major depressive episode
    Pintor, L
    Baillès, E
    Valldeoriola, F
    Tolosa, E
    Martí, MJ
    de Pablo, J
    GENERAL HOSPITAL PSYCHIATRY, 2006, 28 (01) : 59 - 64
  • [43] Tissue-Specific Oxysterols as Predictors of Antidepressant (Escitalopram) Treatment Response in Patients With Major Depressive Disorder
    Sun, Zuoli
    Yang, Jian
    Zhou, Jia
    Zhou, Jingjing
    Feng, Lei
    Feng, Yuan
    He, Yi
    Liu, Min
    Li, Yuhong
    Wang, Gang
    Li, Rena
    BIOLOGICAL PSYCHIATRY: GLOBAL OPEN SCIENCE, 2023, 3 (04): : 663 - 672
  • [44] Adjunctive Cariprazine in Patients With Major Depressive Disorder: Post Hoc Analysis of Efficacy by Baseline Antidepressant Response
    Papakostas, George I.
    Yeung, Paul
    Chen, Chen
    Waraich, Simranpreet
    Kerolous, Majid
    CNS SPECTRUMS, 2023, 28 (02) : 244 - 245
  • [45] Prolactin response to buspirone is not impaired in drug-naive first episode patients with major depressive disorder
    Cubala, Wieslaw Jerzy
    Landowski, Jerzy
    JOURNAL OF AFFECTIVE DISORDERS, 2014, 152 : 468 - 473
  • [46] Association between ABCB1 Polymorphisms and Antidepressant Treatment Response in Taiwanese Major Depressive Patients
    Chang, Hui Hua
    Chou, Chen-Hsi
    Yang, Yen Kuang
    Lee, I. Hui
    Chen, Po See
    CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, 2015, 13 (03) : 250 - 255
  • [47] Increased temporal variability of striatum region facilitating the early antidepressant response in patients with major depressive disorder
    Hou, Zhenghua
    Kong, Youyong
    He, Xiaofu
    Yin, Yingying
    Zhang, Yuqun
    Yuan, Yonggui
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2018, 85 : 39 - 45
  • [48] Association between antidepressant response of milnacipran and plasma concentrations of milnacipran in japanese patients with major depressive disorder
    Naito, S
    Sato, K
    Kamata, M
    Higuchi, H
    Yoshida, K
    Takahashi, H
    Ito, K
    Narumi, A
    Sugawara, Y
    Shimizu, T
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S348 - S348
  • [49] Monoamine oxidase-A gene polymorphism and antidepressant response to fluvoxamine in Japanese patients with major depressive disorder
    Yoshida, K
    Naito, S
    Takahashi, H
    Sato, K
    Ito, K
    Kamata, M
    Higuchi, H
    Shimizu, T
    Itoh, K
    Inoue, K
    Tezuka, T
    Suzuki, T
    Ohkubo, T
    Sugawara, K
    Otani, K
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2003, 18 (03) : 189 - 189
  • [50] Understanding the emotions of patients with inadequate response to antidepressant treatments: results of an international online survey in patients with major depressive disorder
    Mago, Rajnish
    Fagiolini, Andrea
    Weiller, Emmanuelle
    Weiss, Catherine
    BMC PSYCHIATRY, 2018, 18